SEEKIN
SeekIn is focusing on blood-based pan cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030.Cancer early detection is probably the most cost-effective means to reduce cancer mortality as prognosis is much better when cancer is detected and treated at the early stage.
SEEKIN
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.en.seekincancer.com
Total Employee:
11+
Status:
Active
Contact:
400-686-8501
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Content Delivery Network Google Universal Analytics Euro Pound Sterling OpenResty Japanese Yen Alibaba
Current Employees Featured
Founder
Investors List
Green Pine Capital Partners
Green Pine Capital Partners investment in Angel Round - SeekIn
Shenzhenshi IECSZ Fund Investment Management
Shenzhenshi IECSZ Fund Investment Management investment in Angel Round - SeekIn
Official Site Inspections
http://www.en.seekincancer.com
Unable to get host informations!!!
More informations about "SeekIn"
SeekIn
SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can be reduced by 15%.See details»
SeekInCare - SeekIn
With the mission to detect cancer when it is still curable, SeekInCare® has been developed as a pan cancer detection test that takes a panoramic view of blood cell-free cancer signatures and a multi-omics approach incorporating genomic …See details»
SeekIn - Crunchbase Company Profile & Funding
SeekIn is focusing on blood-based pan cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030.Cancer early detection is probably the …See details»
SeekIn Partners With OncoInv to Expand Global Accessibi...
SHENZHEN, China, Dec. 15, 2023 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced a strategic collaboration with Oncolnv, …See details»
SeekIn and OncoInv Collaborate to Expand the Global Accessibility …
Dec 15, 2023 For more information about SeekIn's cutting-edge technologies and products, visit www.seekincancer.com. About Inspire2Live: Inspire2Live was founded in the Netherlands in …See details»
Mao Mao - Inspire2Live
Dr. Mao Mao is Founder and CEO of SeekIn Inc, a start-up focusing on cancer early diagnosis. He is also Adjunct Professor of several universities in Asia.See details»
SeekIn - VentureRadar
SeekIn Inc is a biotech company founded in early 2018 in Shenzhen, China, focusing on blood-based pan cancer early detection utilizing... ... Find out more about ...See details»
SeekIn and OncoInv Collaborate to Expand the Global Accessibility …
Dec 15, 2023 SeekIn envisions that, by leading a new norm for cancer early detection, the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality …See details»
SeekIn and OncoInv Collaborate to Expand the Global Accessibility …
Dec 15, 2023 SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced a strategic collaboration with Oncolnv, a fully-owned affiliate of …See details»
Ground-breaking new technology for multi-cancer early detection …
Dec 11, 2023 SeekIn and OncoInv have joined forces to make multi-cancer early detection (MCED) accessible in low- and middle-income countries (LMICs). SeekIn has developed …See details»
Research - SeekIn
Jan 19, 2024 A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case–control studySee details»
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer …
SHENZHEN, China, Feb. 24, 2022 /PRNewswire/ -- SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) …See details»
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer …
SHENZHEN, China, Feb. 24, 2022 /PRNewswire/ -- SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) …See details»
SeekIn Presents Retrospective and Prospective Validation Studies …
Nov 10, 2023 /PRNewswire/ -- SeekIn Inc., a leader in blood-based pan-cancer early detection and monitoring technology, today announced the validation studies consisting of...See details»
SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer …
Sep 17, 2022 SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can …See details»
Newsroom - SeekIn
Oct 28, 2024 SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at Early Detection of Cancer Conference in …See details»
Who we are and what we do | Canadian Cancer Society
No other organization does all that we do to improve lives today and to change the future of cancer forever. The Impact Report illustrates CCS’s commitment to supporting Canadians with …See details»
OncoSeek - SeekIn
OncoSeek ® was established using artificial intelligence (AI) to distinguish cancer from non-cancer cases by calculating the probability of cancer (POC) index based on the quantification …See details»
Official Website - The Skin Cancer Foundation
Get the best skin cancer information: medically reviewed facts on prevention, early detection, risks, causes & treatment.See details»
SeekIn Presents New OncoSeek® Data at the AACR Annual M...
Two Sample Types, Three Different Platforms, Six Independent Cohorts of ~12,000 Cancer Patients and Non-cancer Individuals with Diverse Ethnic Backgrounds in Retrospective and …See details»